Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 18 (2002), Issue 4, Pages 153-158
http://dx.doi.org/10.1155/2002/591527
Foreword

Nanotechnology: Emerging Developments and Early Detection of Cancer. A Two-Day Workshop Sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30–31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA

Steven J. Zullo,1 Sudhir Srivastava,2 J. Patrick Looney,3 and Peter E. Barker4

1Chemistry and Life Sciences Division, Advanced Technology Program, National Institute of Standards and Technology, Gaithersburg, MD 20899-4730, USA
2Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Plaza North, Suite 3142, Bethesda, MD 20892, USA
3Program Office, National Institute of Standards and Technology, Gaithersburg, Md 20899-8311, USA
4NIST-NCI Biomarkers Validation Laboratory, DNA Technology Group/ Biotechnology Division, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD 20899-8311, USA

Received 12 February 2003; Accepted 12 February 2003

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

A recent meeting jointly sponsored by the National Cancer Institute (NCI) and National Institute of Standards and Technology (NIST) brought together researchers active in nanotechnology and cancer molecular biology to discuss and evaluate the interface between disciplines. Emerging areas where nanotechnologies may impact cancer prevention and early cancer detection were elaborated by key researchers who catalyzed interdisciplinary dialogue aimed at fostering cross-discipline communications and future collaboration.